{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T04:47:50Z","timestamp":1766551670514},"reference-count":28,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.vaccine.2007.01.009","type":"journal-article","created":{"date-parts":[[2007,1,22]],"date-time":"2007-01-22T16:42:40Z","timestamp":1169484160000},"page":"3311-3318","source":"Crossref","is-referenced-by-count":21,"title":["ADP-ribosylation activity in pertussis vaccines and its relationship to the in vivo histamine-sensitisation test"],"prefix":"10.1016","volume":"25","author":[{"given":"S.R.","family":"Gomez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.-T.","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Asokanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Douglas-Bardsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Corbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.G.","family":"Coote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Parton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.K.L.","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.01.009_bib1","unstructured":"Weekly Epidemiological Record. http:\/\/www.who.int\/wer\/2005\/wer8004.pdf, World Health Organisation, 2005;80:29\u201340."},{"key":"10.1016\/j.vaccine.2007.01.009_bib2","series-title":"Pertussis toxin","first-page":"1","article-title":"Biological activities of pertussigen (pertussis toxin)","author":"Munoz","year":"1985"},{"key":"10.1016\/j.vaccine.2007.01.009_bib3","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/bmj.307.6913.1171","article-title":"Pertussis immunisation and serious acute neurological illnesses in children","volume":"307","author":"Miller","year":"1993","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2007.01.009_bib4","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1128\/IAI.69.7.4217-4223.2001","article-title":"Whole-cell but not acellular pertussis vaccines induce convulsive activity in mice: evidence of a role for toxin-induced interleukin-1\u03b2 in a new murine model for analysis of neuronal side effects of vaccination","volume":"69","author":"Donnelly","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.01.009_bib5","unstructured":"Diphtheria-pertussis-tetanus combination vaccine. In: Minimum requirements for Biological products. Association of Biologicals Manufacturers of Japan; 1986:41\u20139."},{"key":"10.1016\/j.vaccine.2007.01.009_bib6","unstructured":"Guidelines for the production and control of the acellular pertussis component of monovalent or combined vaccines. In: WHO Technical Report Series, WHO, 1998;878:57\u201372."},{"key":"10.1016\/j.vaccine.2007.01.009_bib7","unstructured":"Pertussis vaccine. In: U.S. Code of Federal Regulations. Washington DC, U.S. Government Printing Office, 1983; Title21: 58\u201361."},{"key":"10.1016\/j.vaccine.2007.01.009_bib8","unstructured":"Pertussis vaccine (acellular, component, adsorbed), In: European Pharmacopoeia\u2014Supplement, The Directorate for the Quality of Medicines of the Council of Europe (EDQM), 2000:1050\u20131052."},{"issue":"1","key":"10.1016\/j.vaccine.2007.01.009_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1586\/14760584.3.1.89","article-title":"Toxicity and potency evaluation of pertussis vaccines","volume":"3","author":"Corbel","year":"2004","journal-title":"Exp Rev Vaccines"},{"issue":"22","key":"10.1016\/j.vaccine.2007.01.009_bib10","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1021\/bi00265a021","article-title":"Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model","volume":"21","author":"Tamura","year":"1982","journal-title":"Biochemistry"},{"key":"10.1016\/j.vaccine.2007.01.009_bib11","doi-asserted-by":"crossref","first-page":"14647","DOI":"10.1016\/S0021-9258(17)43911-1","article-title":"Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase","volume":"258","author":"Sekura","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2007.01.009_bib12","series-title":"ADP-ribosylaing toxins and G protein","first-page":"45","article-title":"Pertussis toxin as a valuable probe for G-protein: involvement in signal transduction","author":"Ui","year":"1990"},{"issue":"16","key":"10.1016\/j.vaccine.2007.01.009_bib13","doi-asserted-by":"crossref","first-page":"8310","DOI":"10.1016\/S0021-9258(19)68845-9","article-title":"Islet-activating protein. A modifier of receptor-mediated regulation of rat islet adenylate cyclase","volume":"256","author":"Katada","year":"1981","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2007.01.009_bib14","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1016\/S0021-9258(18)32285-3","article-title":"A role of the B-oligomer moiety of islet-activating protein, pertussis toxin, in development of the biological effects on intact cells","volume":"258","author":"Tamura","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2007.01.009_bib15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.2683073","article-title":"Mutants of pertussis toxin suitable for vaccine development","volume":"246","author":"Pizza","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2007.01.009_bib16","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/nm0497-374","article-title":"Rational design of vaccines","volume":"3","author":"Rappuoli","year":"1997","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.vaccine.2007.01.009_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/biol.2001.0280","article-title":"A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products","volume":"29","author":"Cyr","year":"2001","journal-title":"Biologicals"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2007.01.009_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0264-410X(02)00446-2","article-title":"Detection of residual pertussis toxin in vaccines using a modified ribosylation assay","volume":"21","author":"Yuen","year":"2002","journal-title":"Vaccine"},{"issue":"29\u201330","key":"10.1016\/j.vaccine.2007.01.009_bib19","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1016\/S0264-410X(02)00338-9","article-title":"Comparison of the bioactivity of reference preparations for assaying Bordetella pertussis toxin activity in vaccines by the histamine sensitisation and Chinese hamster ovary-cell tests: assessment of validity of expression of activity in terms of protein concentration","volume":"20","author":"Xing","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.01.009_bib20","unstructured":"Diptheria, tetanus and pertussis (acellular, component) vaccine (adsorbed). In: European Pharmacopoeia, The Directorate for the Quality of Medicines of the Council of Europe (EDQM), 2006:3851\u20132."},{"issue":"1","key":"10.1016\/j.vaccine.2007.01.009_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/IAI.55.1.24-28.1987","article-title":"Role of the A subunit of pertussis toxin in alteration of Chinese hamster ovary cell morphology","volume":"55","author":"Burns","year":"1987","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2007.01.009_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0264-410X(95)00230-X","article-title":"The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies","volume":"14","author":"Ibsen","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.01.009_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/biol.1996.0059","article-title":"Collaborative study on test systems to assess toxicity of whole cell pertussis vaccine","volume":"25","author":"van Straaten-van de Kappelle","year":"1997","journal-title":"Biologicals"},{"issue":"8","key":"10.1016\/j.vaccine.2007.01.009_bib24","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1074\/jbc.M310752200","article-title":"Identification of formaldehyde-induced modifications in proteins: reactions with model peptides","volume":"279","author":"Metz","year":"2004","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.vaccine.2007.01.009_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0092-1157(87)90038-2","article-title":"Glutaraldehyde inactivated pertussis vaccine: a less histamine sensitizing vaccine","volume":"15","author":"Gupta","year":"1987","journal-title":"J Biol Stand"},{"issue":"1","key":"10.1016\/j.vaccine.2007.01.009_bib26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0092-1157(87)90020-5","article-title":"The effects of different inactivating agents on the potency, toxicity and stability of pertussis vaccine","volume":"15","author":"Gupta","year":"1987","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2007.01.009_bib27","series-title":"Pertussis toxin","first-page":"19","article-title":"Islet-activating protein, pertussis toxin: subunit structure and mechanism for its multiple biological actions","author":"Ui","year":"1985"},{"key":"10.1016\/j.vaccine.2007.01.009_bib28","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ab.2006.05.012","article-title":"Development of a carbohydrate binding assay for the B-oligomer of pertussis toxin and toxoid","volume":"356","author":"Gomez","year":"2006","journal-title":"Anal Biochem"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07000102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07000102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T23:01:24Z","timestamp":1628377284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07000102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":28,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0264410X07000102"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.01.009","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}